Specific gut bacteria predict cancer immunotherapy response

News-Medical.Net March 2, 2024, 04:00 AM UTC

Summary: A study published in Nature Medicine on 1 March reveals that specific gut bacteria strains can predict positive responses to combination immunotherapy in cancer patients. The research, conducted by the Wellcome Sanger Institute and the Olivia Newton-John Cancer Research Institute, identified a microbiome signature that can be used to develop personalized cancer treatments. The study used samples from a large Australian clinical trial and found that the microbiome impacts treatment response.

Full article

Article metrics
Significance6.0
Scale7.0
Magnitude8.0
Potential9.0
Novelty8.5
Actionability6.0
Immediacy7.0
Positivity9.5
Credibility8.0